m 4 Biobank Alliance & m 4 Trial Service Center
|
|
- Earl Stevenson
- 8 years ago
- Views:
Transcription
1 m 4 Biobank Alliance & m 4 Trial Service Center Services & Consulting in (non-)clinical development
2 m 4 Biobank Alliance Central Access to High Quality Human Biospecimens for R&D
3 The m 4 Biobank Alliance Cooperation Network One-stop Access to Samples of Different Biobanks Source: Department for Pathology, TUM Source: Fotolia The m 4 Biobank Alliance provides access to tissue samples (formalin fixed, fresh and frozen) and to blood samples. Source: Fotolia
4 SERVICES of the m 4 Biobank Alliance Our partner biobanks offer Archive of > tissue and blood based specimens, also matched Broad spectrum of indications Prospective collection according to the user s specifications Source: Department for Pathology, TUM Clinical and anamnetic data, follow up data on demand Analytical services The contact person at Bio M provides an all-round service Single project agreement for all partner-biobanks QA for uniform, high quality of samples and data Coordination of sample and data allocation Scientific and clinical consulting Compliance with high standards for ethics and privacy protection
5 m 4 Biobank Alliance & m 4 Trial Service Center Two Strong Partners for Successful Translation Through close collaboration, m 4 Biobank Alliance and m 4 Trial Service Center offer comprehensive resources for the translation of your project from preclinical to clinical development.
6 m 4 Trial Service Center We guide your project from nonclinical to clinical development!
7 m 4 Trial Service Center (TSC) Our mission We navigate you through the translational development! clinical development nonclinical development Nonclinical development Nonclinical drug development stategies Study designs, planning & management Data review / gap analysis Regulatory documentation Trial preparation Project management Clinical trial protocol Regulatory documentation Consulting on demand Clinical trial Sponsor project management Integration of service providers and study sites Consutling on demand, e.g. regarding monitoring, etc.
8 Our approach Experienced consultants plus a strong network Consulting & resources for your project from a single source! Prof. U. Mansmann Regulatory Biostatistics CROs & Labs Clinicians & Clinical developers Early clinical trial facilities Study sites
9 m 4 Trial Service Center (TSC) Our team: Consultants with longstanding experience Dr. Anneliese Schneider 15+ years industry experience in drug discovery and nonclinical development Senior Expert in Tox, PK, PD (Board Certified) We are your local experts! Lena Mokelke, Dipl.-Biol. 10+ years industry experience in clinical trials Strong project management skills Dr. Martin Sippel Expertise in early drug development Project management and industry consulting experience
10 Selection of references Guidance and services for successful translational development Translational development (I): Comprehensive guidance in the preparation of a Phase I trial We provided advice on the preclinical programs required for the start of clinical development We established a roadmap to enter the clinical trial: Timelines, Roles & Responsibilities, The roadmap was put into practice by our experienced project manager Development and writing of the clinical trial protocol, with mulitdisciplinary input from our network of specialists We also involved service providers from our network Important: Long-term experience of our team to avoid pitfalls!
11 Selection of references Guidance and services for successful translational development Translational development (II): Early advice on preclinical & clinical development strategy Preclinical advice: Results from tox studies were assessed by our team expert By overseeing the whole development process, we assure that regulatory requirements are met Very important: Advice on clinical strategy involvement of experts for the relevant indications from our network
12 Selection of references Guidance and services for successful translational development Preclinical development: General assessment of preclinical program Overall assessment and data evaluation of preclinical safety & pharmacology studies Input by our experienced team expert: Verification of conclusions from preclinical data Advice and recommendations for further procedures in nonclinical development
13 Selection of references Guidance and services for successful translational development For advanced researchers: Our review service Example: clinical trial protocol optimization Our team expert for clinical development initiated study design optimizations during in-depths discussions In close cooperation with our biostatistics partner Prof. Mansmann, we adjusted the number of patients for sufficient statistical power. Also, we enhanced the clarity of trial procedures described in the protocol, leading to a more comprehensive description for study personnel potential for protocol violations is diminished!
14 Selection of references Guidance and services for successful translational development Other topics we advised upon Interaction with authorities Drug-drug interactions, DMPK for small molecules Validation of assays in Personalized Medicine: QM issues for laboratories (in close cooperation with QM experts from our network) Technical validation of assay Clinical validation strategy, trial preparation
15 Thank you! How can we support you? Get in touch with us! Dr. Martin Sippel Phone +49 (0) Mail Web
Mayo Alliance for Clinical Trials
Mayo Alliance for Clinical Trials A Division within Mayo Clinical Trial Services PROFESSIONAL CLINICAL TRIALS SERVICES ADVANCING PATIENT CARE THROUGH SCIENTIFIC DISCOVERY It is a great thing to make scientific
More informationBIOBANK QUALITY. dcarpentieri@phoenixchildrens.com Office: 602-546-1285
BIOBANK QUALITY David F Carpentieri, M.D. Pediatric Pathologist and Biorepository Director, Phoenix Children s Hospital Assistant Professor of Pediatrics and Clinical Pathology, University of Arizona Assistant
More informationMayo Central Laboratory for Clinical Trials A Division within Mayo Clinical Trial Services
Mayo Central Laboratory for Clinical Trials A Division within Mayo Clinical Trial Services LABORATORY TESTING SERVICES YOUR PARTNER IN LABORATORY MEDICINE The key note of progress in the 20th century is
More informationCareers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA
PharmaSUG 2014 Paper CP07 Careers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA ABSTRACT In the biopharmaceutical
More informationProfessional Certificate in Primary Care Psychology
Professional Certificate in Primary Care Psychology The NAPPP Primary Care Psychology Certificate training program requires the completion of 10 courses. Each course awards 15 CE credit hours. NAPPP is
More informationMedical Psychology Certificate Program Information
Medical Psychology Certificate Program Information The Medical Psychology Professional Certificate Program requires the completion of 10 courses for a total of 300 hours. The program is consistent with
More informationLilly Covance Strategic Alliance From Vision to Results. Adrienne Takacs, PhD Jonathan Koch, MBA
Lilly Covance Strategic Alliance From Vision to Results Adrienne Takacs, PhD Jonathan Koch, MBA Topics 1. Lilly s Challenge... a Partnership Opportunity 2. Our Landmark Agreement 3. A Local Success Story
More informationFuture Biobanking- Developing Smart, Sustainable And Ethically Compliant Biorepositories Market Research By MarketResearchReports.
Future Biobanking- Developing Smart, Sustainable And Ethically Compliant Biorepositories Market Research By MarketResearchReports.Biz MarketResearchReports.Biz Recently Announced Research Report And Forecast
More informationOrganization and Job Profile
Organization and Job Profile New Orleans, Louisiana Position: Reports to: Location: System Vice President for Research New Orleans, Louisiana CORPORATE BACKGROUND is a non-profit, academic, multi-specialty,
More informationTHE BIOTECH & PHARMACEUTICAL INDUSTRY
THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues
More informationSheffield Kidney Institute. Planning a Clinical Trial
Planning a Clinical Trial Clinical Trials Testing a new drug Ethical Issues Liability and Indemnity Trial Design Trial Protocol Statistical analysis Clinical Trials Phase I: Phase II: Phase III: Phase
More informationI. INTRODUCTION DEFINITIONS AND GENERAL PRINCIPLE
Final: Approved by Partners Professional and Institutional Conduct Committee 8/11/04 Policy on Transfers to Third Parties Of Tissues, Other Specimens, and Data Obtained by Partners-Affiliated Providers
More informationSCIENTIFIC SUBSTANTIATION OF STANDARD OPERATIONAL PROCEDURES ROLE IN QUALITY ASSURANCE SYSTEM IN CLINICAL DRUG TRIALS
UDC 615:519.076 Dobrova V. Ye., Zupanets K. O., Ratushna K. L. National University of Pharmacy SCIENTIFIC SUBSTANTIATION OF STANDARD OPERATIONAL PROCEDURES ROLE IN QUALITY ASSURANCE SYSTEM IN CLINICAL
More informationContact. Laboratory for Clinical Trials Laboratoire des Essays Cliniques Laboratorio de Ensayos Clinicos
Contact LKF - Laboratorium für Klinische Forschung GmbH Lise-Meitner-Straße 25-29 D-24223 Raisdorf, Germany Phone: +49(0)43 07-82 76 0 Fax: +49(0)43 07-82 76 79 Internet: www.lkf-kiel.de E-mail: project@lkf-kiel.de
More informationThe Clinical Trials Process an educated patient s guide
The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-
More informationComprehensive Sample Management Solutions
Comprehensive Sample Management Solutions Discover the Hidden Value in Your Sample Assets solutions consulting sample storage sample bioprocessing onsite/offsite operations management logistics/relocation
More informationAchieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013
Achieving Regulatory Success: Areas of focus for biotechnology companies Michael J. Schlosser, PhD, DABT April 21, 2013 Regulatory Success Outline Regulatory Initiatives Regulatory Science Pre-Regulatory
More informationCLINICAL RESEARCH GENERIC TASK DESCRIPTIONS
Purpose Purpose Purpose Primary responsibility for implementation, coordination, evaluation, communication and/or management of research studies. May involve more than one study or multiple sites within
More informationThe NIH Roadmap: Re-Engineering the Clinical Research Enterprise
NIH BACKGROUNDER National Institutes of Health The NIH Roadmap: Re-Engineering the Clinical Research Enterprise Clinical research is the linchpin of the nation s biomedical research enterprise. Before
More informationGuidance for Industry
Guidance for Industry End-of-Phase 2A Meetings U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) September 2009 Procedural Guidance
More informationNational Cancer Institute
National Cancer Institute Taking Part in Cancer Treatment Research Studies U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Taking Part in Cancer Treatment Research Studies If
More informationThe Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor
The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality
More informationBioWales 2015 Pharmaceutical Supply Chain Showcase. 04 March 2015
BioWales 2015 Pharmaceutical Supply Chain Showcase 04 March 2015 SIMBEC RESEARCH 40 YEARS EXPERIENCE IN EARLY STAGE CLINICAL DRUG DEVELOPMENT BACKGROUND Over 1,200 clinical studies safely and successfully
More informationOffice of Clinical Research and the. Institute (CTSI) Patricia Emmanuel, MD
Office of Clinical Research and the Clinical and Translational Research Institute (CTSI) Patricia Emmanuel, MD Office of Clinical Research- Priorities Review processes for clinical study implementation,
More informationROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
More informationClinical Research Infrastructure at the European level: the ECRIN model. Christine Kubiak ECRIN Coordination Inserm- DRCT
Clinical Research Infrastructure at the European level: the RIN model Christine Kubiak RIN Coordination Inserm- DRCT Finland FinnCRIN Ireland ICRIN UK UKCRN France Inserm Denmark DCRIN Germany KKS Switzerland
More informationGLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com
GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process
More informationOverview of Phase 1 Oncology Trials of Biologic Therapeutics
Overview of Phase 1 Oncology Trials of Biologic Therapeutics Susan Jerian, MD ONCORD, Inc. February 28, 2008 February 28, 2008 Phase 1 1 Assumptions and Ground Rules The goal is regulatory approval of
More informationDiagnostic Tests. Brad Spring Director, Regulatory Affairs
Regulatory Challenges in the Development of Diagnostic Tests Industry Perspective Brad Spring Director, Regulatory Affairs September 28, 2011 Balancing Evidence of Safety & Effectiveness and Time to Market
More informationData Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International
Data Management and Good Clinical Practice Patrick Murphy,, Family Health International 1 What is GCP? Good Clinical Practice is an international ethical and scientific quality standard for designing,
More informationThe Role of the CRO in Effective Risk-Based Monitoring
New Whitepaper The Role of the CRO in Effective Risk-Based Monitoring The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging
More informationMaster of Science in Biomedical Sciences
Master of Science in Biomedical Sciences Faculty of Medicine Good health is our greatest treasure. Understanding the human body, healthy and diseased, is the stepping stone to finding tools to improving
More informationDMPK: Experimentation & Data
DMPK: Experimentation & Data Interpretation Mingshe Zhu, Mike S. Lee, Naidong Weng, and Mark Hayward Prerequisite: Entry-level scientists with hands on experience in LC/MS as well as advanced students
More informationPatient Handbook on Stem Cell Therapies
Patient Handbook on Stem Cell Therapies Appendix I of the Guidelines for the Clinical Translation of Stem Cells www.isscr.org 2008, International Society for Stem Cell Research 2 Introduction We have all
More informationJoint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 The innovative pharmaceutical industry 2 is committed to the transparency
More informationAnnex 7 Guidelines for the preparation of a contract research organization master file
World Health Organization WHO Technical Report Series, No. 957, 2010 Annex 7 Guidelines for the preparation of a contract research organization master file Background 1. General information 2. Quality
More informationIBCSG Tissue Bank Policy
THE INTERNATIONAL BREAST CANCER STUDY GROUP IBCSG Tissue Bank Policy Accepted by the IBCSG Executive Committee on March 24, 2006 Accepted by the IBCSG Ethics Committee on March 24, 2006 Accepted by the
More informationGOVERNANCE AND THE EHR4CR INSTITUTE
GOVERNANCE AND THE EHR4CR INSTITUTE Dipak Kalra EuroRec, University College London Christian Ohmann, European Clinical Research Infrastructure Network (ECRIN) Electronic Health Records for Clinical Research
More informationRECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING
RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING July 2006 TABLE OF CONTENTS Page 1. Introduction 2 2. Scope 2 3. Documents to be archived 2 4. Quality of essential documents 10 5.
More informationPrincipal Investigator and Sub Investigator Responsibilities
Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal
More informationStructure of State Regulatory Authorities REGISTRATION CERTIFICATE ISSUING AUTHORITY ROSZDRAVNADZOR
PRESENTATION REGISTRATION OF PHARMACEUTICAL PRODUCTS IN RUSSIA Alyona Chorich, Regulatory Affairs Manager PharmaReg, Moscow 1. Registration in Russia conception. Pharmaceutical products / food supplements
More informationGlobal healthcare solutions
Global healthcare solutions clinical trials pharma/biotech medical technology & supplies Global healthcare solutions for your peace-of-mind A global network with specialist options Global presence with
More informationRegulatory Issues in Genetic Testing and Targeted Drug Development
Regulatory Issues in Genetic Testing and Targeted Drug Development Janet Woodcock, M.D. Deputy Commissioner for Operations Food and Drug Administration October 12, 2006 Genetic and Genomic Tests are Types
More informationIS YOUR PROJECT HUMAN SUBJECTS RESEARCH. A Guide for Investigators. Jacksonville University Institutional Review Board DEFINING RESEARCH
IS YOUR PROJECT HUMAN SUBJECTS RESEARCH? A Guide for Investigators HUMAN SUBJECTS RESEARCH Research projects involving human subjects require review and approval by an Institutional Review Board. An IRB
More informationResearch Resources at Partners Hospitals
Research Resources at Partners Hospitals Barbara E. Bierer, M.D. SVP Research, BWH bbierer@partners.org (617) 732-8990 Rick Bringhurst, M.D. SVP Research, MGH rbringhurst@partners.org (617) 724-8549 Agenda
More informationStrategies to Prepare for Meetings with the FDA. Kim Colangelo Associate Director for Regulatory Affairs Office of New Drugs, CDER, FDA
Strategies to Prepare for Meetings with the FDA Kim Colangelo Associate Director for Regulatory Affairs Office of New Drugs, CDER, FDA Topics for Discussion Who Are We? How Do We Interact Internally? Why
More informationCommonwealth Advanced Data Analytics Alliance & The President s Precision Medicine Initiative
Commonwealth Advanced Data Analytics Alliance & The President s Precision Medicine Initiative Deputy Secretary Anthony Fung Presentation to the Health IT Standards Advisory Committee December 17, 2015
More informationPhysician Assistant Studies
Physician Assistant Studies Physician Assistant Phone: (540) 568-8171 Website: http://www.jmu.edu/heathsci/paweb Interim Academic Unit Head Dr. Paula Maxwell Graduate Program Director Mr. James Hammond,
More informationConditions for Accreditation as (Basic) Pharmacologist
NEDERLANDSE VERENIGING VOOR FARMACOLOGIE DUTCH PHARMACOLOGICAL SOCIETY Conditions for Accreditation as (Basic) Pharmacologist 1. Introduction The Dutch Pharmacological Society (DPS) is the organization
More informationGeneral Clinical Research Center at Stony Brook
General Clinical Research Center at Stony Brook General Clinical Research Center at Stony Brook National Institute of Health funded for over $1 million per year for center s operation to help improve health
More informationNIH MENTORED CAREER DEVELOPMENT AWARDS (K01, K08, K23)
NIH MENTORED CAREER DEVELOPMENT AWARDS (K01, K08, K23) Note: the information below is extracted from the current Program Announcements; before applying for a K award you should obtain and read the most
More informationReflections on Establishing a Masters Degree in Research Biobanking. Cheryl Gillett King s Health Partners Cancer Biobank
Reflections on Establishing a Masters Degree in Research Biobanking Cheryl Gillett King s Health Partners Cancer Biobank Why Create a Masters Degree Programme? Demand for access to high quality material
More informationBalancing Big Data for Security, Collaboration and Performance
Balancing Big Data for Security, Collaboration and Performance Sai Balu Lineberger Cancer Center UNC Chapel Hill Oct 14, 2014 About UNC Oldest Public University -1793 Top 5 Public University. 46th World
More informationSERVICES FOR. Devices and Combination Products
SERVICES FOR Devices and Combination Products How to Contact Us U.S. FACILITIES / CLIENT SERVICES St. Paul 2540 Executive Drive St. Paul, MN 55120 FAX 651.675.2005 Atlanta 1265 Kennestone Circle Marietta,
More informationCTC Technology Readiness Levels
CTC Technology Readiness Levels Readiness: Software Development (Adapted from CECOM s Software Technology Readiness Levels) Level 1: Basic principles observed and reported. Lowest level of software readiness.
More informationCLINICAL TRIALS: FOCUS VS. DRIVING EFFICIENCIES BLINDLY
www.5amsolutions.com CLINICAL TRIALS: FOCUS VS. DRIVING EFFICIENCIES BLINDLY Continuing downward pressures on healthcare economics, diminished outcomes, patent cliffs, and antiquated R&D models are among
More informationSTANDARD OPERATING POLICY AND PROCEDURE
STANDARD OPERATING POLICY AND PROCEDURE SUBJECT: Biospecimen Request and Release Policy Number: 500.0 Policy Date: 1/16/2009 Amendment Date: N/A Revision Date: 5-3-2010 I. INTRODUCTION AND PURPOSE The
More informationIntroduction to Clinical Research
Introduction to Clinical Research NCURA Region I Spring Meeting May 5, 2015 Agenda Introductions Brief History of Clinical Research Clinical Research in Context Clinical Research Compliance Clinical Research
More informationTo know more about Pharmacovigilance and Clinical Trials Data Management
To know more about Pharmacovigilance and Clinical Trials Data Management 1. What is Pharmacovigilance? Pharmacovigilance (PV) is the pharmacological science related to the detection, assessment, understanding
More informationNeeds, Providing Solutions
Identifying Needs, Providing Solutions 1 I n d u s t r y The growth of medical research and the countless innovations coming from the pharmaceutical, biotechnology and medical device industry, has improved
More informationClinical Data Management Overview
The 2 nd Clinical Data Management Training Clinical Data Management Overview Andrew Taylor ( 安 泰 乐 ), M.S. Head of Clinical Data Management August 30, 2010 Learning Objectives Overview of Process Related
More informationEven we will get to use your product someday. Enough reason for us to deliver.
Even we will get to use your product someday. Enough reason for us to deliver. ClinInvent: Putting our heart and soul behind the research. At ClinInvent, when we talk about clinical research it s not just
More informationUniversity of California, Irvine. (December 4, 2010, Sapporo, Japan)
University of California, Irvine 1 2 (December 4, 2010, Sapporo, Japan) This article is an invaluable record of an interview with Prof. Ruth Mulnard, who is a nursing scientist as well as a clinician in
More informationFiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements
Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements PCRP AWARD MECHANISMS WITH EMPHASIS ON RESOURCES Clinical Consortium Award
More informationEMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART Framework Labs generate data that are used to make decisions on the safety and efficacy of medicinal products; consequently,
More informationUnited States Small Business Administration Office of Hearings and Appeals
Cite as: NAICS Appeal of Information Ventures, Inc., SBA No. NAICS-4882 (2008) United States Small Business Administration Office of Hearings and Appeals NAICS APPEAL OF: Information Ventures, Inc. Appellant
More informationSAS Drug Development User Connections Conference 23-24Jan08
SAS Drug Development User Connections Conference 23-24Jan08 Bernd Doetzkies David Ramage Daiichi Sankyo Pharma Development DSPD Clinical Data Repository System Business Drivers System Overview People and
More informationCTRNet Standard Operating Procedure Job Descriptions, Roles and Responsibilities
CTRNet Standard Operating Procedure SOP Number: 01.006 Version: e2.0 Supersedes: 1.1.102 e1.0 Category: Administration 1.0 PURPOSE Approved By: CTRNet Management Group Per: Brent Schacter 01-May-2012 28-May-2012
More informationHow To Get A Grant From Kinesis
- The collaboration initiative to move drug candidates forward Introduction What are we offering? How? Why apply? Terms Background For grant applications and to attract venture capital start-up companies
More informationTemplate for essential information to be provided for proposals including clinical trials / studies / investigations
Template for essential information to be provided for proposals including clinical trials / studies / investigations Document history Version 2016callsV1 September 2015 Modifications (compared to previous
More informationBiobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC
Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC ISCT Conference, New Zealand, April 2013 April 1 st 2013 NIBSC will become part of the Medicines and
More informationMaster of Science in Vision Science and Investigative Ophthalmology MVSIO
Master of Science in Vision Science and Investigative Ophthalmology MVSIO Global Leadership in Eye Care, Vision Research and Ophthalmology Education Bascom Palmer Eye Institute is pleased to introduce
More informationLifeLines Cohort Study. Salome Scholtens, Manager Research Office
LifeLines Cohort Study Salome Scholtens, Manager Research Office What is LifeLines? Biobank» LifeLines Cohort & Biorepository 165,000 participants at least 30 years follow-up Three generation design Northern
More informationSpecialty Lab and Immunological Testing Services
Specialty Lab and Immunological Testing Services OVER 30 YEARS OF SPECIALTY LAB EXPERIENCE Precision for Medicine recognizes the critical role that sample testing and handling play in achieving high-quality,
More informationASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE
ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE THIS POLICY OUTLINES THE TOP LEVEL REQUIREMENTS TO SUPPORT PRODUCT QUALITY IN THE DEVELOPMENT, MANUFACTURE AND DISTRIBUTION OF ACTIVE PHARMACEUTICAL
More informationUse of Electronic Health Records in Clinical Research: Core Research Data Element Exchange Detailed Use Case April 23 rd, 2009
Use of Electronic Health Records in Clinical Research: Core Research Data Element Exchange Detailed Use Case April 23 rd, 2009 Table of Contents 1.0 Preface...4 2.0 Introduction and Scope...6 3.0 Use Case
More informationTransforming relationships Unleashing innovation
Transforming relationships Unleashing innovation Translating Discoveries Into Products A model for innovation driven economic growth Barbara Handelin, PhD 1 The Innovation Gap Economic Opportunity Industries
More informationECONOMIC FOOTPRINT OF CTs IN BELGIUM STRATEGIC PLAN TO PROMOTE CTs
ECONOMIC FOOTPRINT OF CTs IN BELGIUM STRATEGIC PLAN TO PROMOTE CTs Ingrid Maes Director Pharma, Healthcare and Life Sciences PwC on behalf of: PwC on behalf of: PwC on behalf of: PwC PwC on behalf of:
More informationRESEARCH INVOLVING DATA AND/OR BIOLOGICAL SPECIMENS
RESEARCH INVOLVING DATA AND/OR BIOLOGICAL SPECIMENS 1. Overview IRB approval and participant informed consent are required to collect biological specimens for research purposes. Similarly, IRB approval
More informationVoluntary Genomic Data Submissions at the U.S. FDA
Voluntary Genomic Data Submissions at the U.S. FDA International Conference on Harmonization Chicago, IL November 9-10, 9 2005 Felix W. Frueh, PhD Associate Director for Genomics Office of Clinical Pharmacology
More informationMeeting Priorities of Biotech & Small Pharma Companies
Meeting Priorities of Biotech & Small Pharma Companies Dr. Andreas Orfanos, MBBCH,FFPM,MBA Thrasos Therapeutics Inc. Vice President Clinical Research & Development 28 Oct 2015 Montreal Technoparc Private,
More informationMASTERS IN PUBLIC HEALTH (M.A.)
MASTERS IN PUBLIC HEALTH (M.A.) Department of Social Sciences Course Director : Prof. J.K. Das Coordinators : Prof. A.M. Khan Prof. T. Bir Co- coordinator : Dr. A.M. Elizabeth Course Associate : Mr. Bacchu
More informationProduct Lifecycle Management for the Pharmaceutical Industry
Product Lifecycle Management for the Pharmaceutical Industry An Oracle White Paper Author: Todd Hein, Oracle Life Sciences Key Contributors: i. Arvindh Balakrishnan, Oracle Life Sciences ii. Hardeep Gulati,
More informationPROCEDURE FOR PREPARING GCP INSPECTIONS REQUESTED BY THE EMEA. GCP Inspectors Working Group
European Medicines Agency Inspections London, 20 September 2007 EMEA/INS/GCP/197228/2005 Procedure no.: INS/GCP/2 PROCEDURE FOR PREPARING GCP INSPECTIONS REQUESTED BY THE EMEA GCP Inspectors Working Group
More informationTAKING PART IN CANCER TREATMENT RESEARCH STUDIES
For more infomation about Cancer Clinical Trials at Upstate Cancer Center please call Upstate Connect 1.800.464.8668 TAKING PART IN CANCER TREATMENT RESEARCH STUDIES Information provided by: National Cancer
More informationMedical Device Solutions. Battelle. Applied Research Device Development Clinical Research Sustaining Engineering
Medical Device Solutions Battelle Applied Research Device Development Clinical Research Sustaining Engineering 0 2 Overview Applied Research Device Development Clinical Research Sustaining Engineering
More informationComprehensive Data Resource Introduction
National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Comprehensive Data Resource Introduction Helen Moore and Ping Guan Biorepositories and Biospecimen Research
More informationNon-clinical development of biologics
Aurigon Life Science GmbH Non-clinical development of biologics Requirements, challenges and case studies Committed to Life. Sigrid Messemer vet. med. M4 Seminar March 10 th 2014 Aurigon - your full service
More informationA Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations
A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations Ce3, Inc. and Insight Genetics, Inc. Oncology Forum July 15, 2015 Agenda Introductions Definitions Regulations
More informationAnnex A. Levels 1 5 of the Clinical Research Coordinator Track in the Clinical Research WSQ Framework
Annex A Levels 1 5 of the Clinical Research Coordinator Track in the Clinical Research WSQ Framework WSQ Higher Certificate in Clinical Research (Clinical Research Coordinators) Apply Drug Development
More informationEnrico Invernizzi Alessandra Grande
Con il contributo educazione di Enrico Invernizzi Alessandra Grande Roma, venerdì 1 marzo 2013 Merck Serono - RBM, Colleretto Giacosa, Italy Outline Regulatory enviroment Biomarkers: What and why Which
More informationMediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015
19th of March 2015 MediSapiens Ltd Because data is not knowledge Bio-IT solutions for improving cancer patient care Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2015 MediSapiens Ltd. All
More informationNo. 706. Page 1 of 5. Issue Date 4/21/2014
Subject: ROUTINE MONITORING VISITS Standard Operating Procedure Prepared By: Beaumont Research Coordinating Center, Research Institute PURPOSE Prior Issue Date 8/15/2011 No. 706 Issue Date 4/21/2014 Page
More informationSummary of the role and operation of NHS Research Management Offices in England
Summary of the role and operation of NHS Research Management Offices in England The purpose of this document is to clearly explain, at the operational level, the activities undertaken by NHS R&D Offices
More informationCall 2014: High throughput screening of therapeutic molecules and rare diseases
Call 2014: High throughput screening of therapeutic molecules and rare diseases The second call High throughput screening of therapeutic molecules and rare diseases launched by the French Foundation for
More informationRegulatory Compliance
PART-TIME MASTER S DEGREE PROGRAM Regulatory Compliance Choose from program tracks in healthcare compliance, clinical research or quality and regulatory science. Expand your professional opportunities
More informationJobbetegnelser for det nuværende job i branchen
Jobbetegnelser for det nuværende job i branchen Administrerende direktør (CEO) Academic, Project manage Advanced Business Analyst Advanced Business Analyst, IT&CD, IT System Management Analytical Service
More informationFDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS
SMG 1117.22a FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS FOOD AND DRUG ADMINISTRATION OFFICE OF OPERATIONS OFFICE OF INFORMATION MANAGEMENT AND TECHNOLOGY OFFICE OF INFORMATICS AND
More informationThe Evolution of Data Management Job Models. in the Execution of Clinical Trials. info@kcr.com. www.kcrcro.com
The Evolution of Data Management Job Models in the Execution of Clinical Trials info@kcr.com KCR S.A. Corporate Headquarters 6 Postepu str., 02-676 Warsaw Phone: +48 22 313 13 13 Fax: +48 22 313 13 14
More information